Balchem Key Executives
This section highlights Balchem's key executives, including their titles and compensation details.
Find Contacts at Balchem
(Showing 0 of )
Balchem Earnings
This section highlights Balchem's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-21 | $1.11 | $1.03 |
| Read Transcript | Q3 | 2024 | 2024-10-25 | $1.11 | $1.13 |
| Read Transcript | Q2 | 2024 | 2024-07-26 | $1.03 | $1.09 |
| Read Transcript | Q1 | 2024 | 2024-05-03 | $0.98 | $1.03 |
| Read Transcript | Q4 | 2023 | 2024-02-16 | $0.93 | $0.95 |
| Read Transcript | Q3 | 2023 | 2023-10-27 | $0.97 | $1.04 |
| Read Transcript | Q2 | 2023 | 2023-07-28 | $0.84 | $1.06 |
| Read Transcript | Q1 | 2023 | 2023-04-28 | $0.78 | $0.70 |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
$164.52
Stock Price
$5.35B
Market Cap
1.36K
Employees
New Hampton, NY
Location
Financial Statements
Access annual & quarterly financial statements for Balchem, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $953.68M | $922.44M | $942.36M | $799.02M | $703.64M |
| Cost of Revenue | $617.48M | $620.38M | $661.91M | $555.85M | $479.75M |
| Gross Profit | $336.21M | $302.06M | $280.45M | $243.17M | $223.90M |
| Gross Profit Ratio | 35.25% | 32.70% | 29.76% | 30.40% | 31.82% |
| Research and Development Expenses | $16.79M | $15.05M | $12.19M | $13.52M | $10.33M |
| General and Administrative Expenses | $67.59M | $55.73M | $55.66M | $41.73M | $43.79M |
| Selling and Marketing Expenses | $68.92M | $74.40M | $67.41M | $60.41M | $58.63M |
| Selling General and Administrative Expenses | $136.50M | $130.13M | $123.07M | $102.15M | $102.42M |
| Other Expenses | $- | $- | $-11.44M | $-2.27M | $-4.73M |
| Operating Expenses | $153.30M | $142.86M | $135.26M | $115.67M | $112.75M |
| Cost and Expenses | $770.77M | $763.25M | $797.17M | $671.52M | $592.50M |
| Interest Income | $- | $- | $2.25M | $2.26M | $2.27M |
| Interest Expense | $16.53M | $22.61M | $10.27M | $2.46M | $4.44M |
| Depreciation and Amortization | $- | $54.94M | $51.30M | $45.76M | $49.00M |
| EBITDA | $182.91M | $214.81M | $197.57M | $175.70M | $162.13M |
| EBITDA Ratio | 19.18% | 23.29% | 20.91% | 22.07% | 23.08% |
| Operating Income | $182.91M | $159.19M | $145.19M | $127.50M | $111.15M |
| Operating Income Ratio | 19.18% | 17.26% | 15.41% | 15.96% | 15.80% |
| Total Other Income Expenses Net | $-16.46M | $-21.93M | $-11.44M | $-2.27M | $-4.73M |
| Income Before Tax | $166.45M | $137.26M | $133.75M | $125.23M | $106.42M |
| Income Before Tax Ratio | 17.45% | 14.88% | 14.19% | 15.67% | 15.12% |
| Income Tax Expense | $37.98M | $28.72M | $28.38M | $29.13M | $21.79M |
| Net Income | $128.47M | $108.54M | $105.37M | $96.10M | $84.62M |
| Net Income Ratio | 13.47% | 11.77% | 11.18% | 12.03% | 12.03% |
| EPS | $3.97 | $3.38 | $3.29 | $2.98 | $2.63 |
| EPS Diluted | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 |
| Weighted Average Shares Outstanding | 32.33M | 32.11M | 32.02M | 32.22M | 32.18M |
| Weighted Average Shares Outstanding Diluted | 32.72M | 32.45M | 32.39M | 32.67M | 32.50M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $240.00M | $239.94M | $234.08M | $239.66M | $228.70M | $229.95M | $231.25M | $232.54M | $232.53M | $244.27M | $236.69M | $228.87M | $213.13M | $197.87M | $202.37M | $185.66M | $180.71M | $175.14M | $173.35M | $174.44M |
| Cost of Revenue | $153.67M | $154.58M | $151.09M | $158.15M | $153.71M | $153.40M | $153.90M | $159.37M | $163.89M | $175.84M | $164.82M | $157.36M | $149.07M | $136.94M | $142.92M | $126.93M | $123.89M | $118.77M | $117.97M | $119.11M |
| Gross Profit | $86.34M | $85.36M | $82.99M | $81.51M | $74.99M | $76.54M | $77.35M | $73.17M | $68.64M | $68.43M | $71.88M | $71.51M | $64.07M | $60.93M | $59.45M | $58.73M | $56.82M | $56.37M | $55.38M | $55.33M |
| Gross Profit Ratio | 35.97% | 35.60% | 35.50% | 34.00% | 32.80% | 33.30% | 33.40% | 31.50% | 29.50% | 28.00% | 30.40% | 31.20% | 30.10% | 30.80% | 29.40% | 31.60% | 31.44% | 32.18% | 31.95% | 31.72% |
| Research and Development Expenses | $4.51M | $4.33M | $3.85M | $4.10M | $3.94M | $3.87M | $3.79M | $3.45M | $3.04M | $3.00M | $2.92M | $3.23M | $4.72M | $3.16M | $2.90M | $2.75M | $2.37M | $2.69M | $2.57M | $2.70M |
| General and Administrative Expenses | $17.27M | $17.48M | $15.33M | $17.51M | $13.45M | $10.80M | $12.03M | $17.13M | $14.45M | $15.22M | $13.04M | $12.95M | $10.36M | $9.79M | $11.11M | $10.48M | $10.38M | $10.42M | $12.06M | $10.92M |
| Selling and Marketing Expenses | $17.12M | $15.56M | $18.01M | $18.23M | $19.27M | $18.26M | $18.68M | $18.18M | $17.84M | $16.59M | $15.99M | $16.98M | $15.16M | $15.48M | $14.85M | $14.92M | $15.14M | $14.22M | $13.84M | $15.43M |
| Selling General and Administrative Expenses | $34.38M | $33.04M | $33.21M | $35.30M | $11.28M | $29.06M | $30.72M | $35.31M | $32.29M | $31.81M | $29.03M | $29.94M | $25.52M | $25.27M | $25.95M | $25.40M | $25.52M | $24.65M | $25.89M | $26.35M |
| Other Expenses | $- | $- | $-331.00K | $572.00K | $223.00K | $-7.14M | $727.00K | $-5.29M | $-7.53M | $1.10M | $298.00K | $-161.00K | $-675.00K | $128.00K | $-574.00K | $133.00K | $-877.00K | $-1.12M | $16.00K | $-92.00K |
| Operating Expenses | $38.89M | $37.37M | $37.06M | $39.40M | $15.21M | $32.93M | $-34.51M | $38.76M | $35.33M | $34.80M | $31.96M | $33.17M | $30.25M | $28.42M | $28.85M | $28.15M | $27.89M | $27.34M | $28.46M | $29.05M |
| Cost and Expenses | $192.56M | $191.95M | $188.15M | $197.54M | $168.92M | $186.33M | $-34.51M | $198.13M | $199.23M | $210.64M | $196.77M | $190.53M | $179.31M | $165.36M | $171.77M | $155.08M | $151.79M | $146.11M | $146.44M | $148.16M |
| Interest Income | $- | $- | $- | $- | $- | $6.59M | $569.00K | $550.00K | $568.00K | $569.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $2.82M | $4.07M | $4.24M | $5.40M | $5.29M | $6.59M | $5.16M | $5.57M | $5.12M | $3.64M | $960.00K | $545.00K | $567.00K | $556.00K | $608.00K | $725.00K | $830.00K | $953.00K | $960.00K | $1.70M |
| Depreciation and Amortization | $- | $10.90M | $12.51M | $13.67M | $13.53M | $13.80M | $13.43M | $13.65M | $13.89M | $14.10M | $11.93M | $11.86M | $11.41M | $11.40M | $11.34M | $11.61M | $12.93M | $13.05M | $12.74M | $12.55M |
| EBITDA | $47.44M | $58.87M | $57.97M | $55.78M | $52.09M | $56.87M | $57.56M | $48.88M | $45.35M | $49.39M | $52.71M | $50.19M | $45.70M | $44.80M | $30.59M | $42.87M | $41.81M | $43.04M | $39.68M | $38.73M |
| EBITDA Ratio | 19.77% | 24.53% | 24.96% | 23.28% | 32.05% | 18.97% | 24.33% | 20.66% | 14.32% | 19.99% | 22.03% | 21.89% | 15.87% | 22.64% | 15.12% | 23.20% | 23.16% | 16.57% | 22.89% | 22.21% |
| Operating Income | $47.44M | $47.99M | $45.93M | $42.12M | $59.78M | $43.61M | $42.84M | $34.41M | $19.41M | $33.62M | $39.92M | $38.34M | $33.82M | $32.51M | $30.59M | $30.57M | $28.92M | $29.03M | $26.92M | $26.28M |
| Operating Income Ratio | 19.77% | 20.00% | 19.62% | 17.57% | 26.14% | 18.97% | 18.52% | 14.80% | 8.35% | 13.77% | 16.87% | 16.75% | 15.87% | 16.43% | 15.12% | 16.47% | 16.01% | 16.57% | 15.53% | 15.06% |
| Total Other Income Expenses Net | $-2.96M | $-4.10M | $-4.57M | $-4.83M | $-5.07M | $-7.14M | $-4.44M | $-5.29M | $6.36M | $-2.54M | $-662.00K | $-706.00K | $-675.00K | $-428.00K | $-574.00K | $-592.00K | $-877.00K | $-1.12M | $-944.00K | $-1.79M |
| Income Before Tax | $44.48M | $43.89M | $41.23M | $36.85M | $33.27M | $36.48M | $38.40M | $29.12M | $25.78M | $31.09M | $39.26M | $37.63M | $33.15M | $32.09M | $30.02M | $29.98M | $28.05M | $27.91M | $25.97M | $24.49M |
| Income Before Tax Ratio | 18.53% | 18.29% | 17.61% | 15.38% | 14.55% | 15.86% | 16.61% | 12.52% | 11.08% | 12.73% | 16.59% | 16.44% | 15.55% | 16.22% | 14.83% | 16.15% | 15.52% | 15.93% | 14.98% | 14.04% |
| Income Tax Expense | $10.90M | $10.06M | $9.16M | $7.86M | $6.62M | $7.40M | $8.29M | $6.41M | $4.37M | $5.84M | $9.48M | $8.70M | $8.20M | $7.07M | $7.29M | $6.57M | $5.88M | $6.34M | $4.85M | $4.72M |
| Net Income | $33.58M | $33.84M | $32.07M | $28.99M | $26.65M | $29.07M | $30.11M | $22.71M | $21.41M | $25.25M | $29.78M | $28.93M | $24.95M | $25.01M | $22.73M | $23.41M | $22.16M | $21.57M | $21.12M | $19.77M |
| Net Income Ratio | 13.99% | 14.10% | 13.70% | 12.09% | 11.65% | 12.64% | 13.02% | 9.77% | 9.21% | 10.34% | 12.58% | 12.64% | 11.71% | 12.64% | 11.23% | 12.61% | 12.26% | 12.31% | 12.19% | 11.33% |
| EPS | $1.03 | $1.05 | $0.99 | $0.90 | $0.83 | $0.91 | $0.94 | $0.71 | $0.67 | $0.79 | $0.93 | $0.90 | $0.77 | $0.78 | $0.70 | $0.73 | $0.68 | $0.67 | $0.66 | $0.62 |
| EPS Diluted | $1.03 | $1.03 | $0.98 | $0.89 | $0.82 | $0.90 | $0.93 | $0.70 | $0.66 | $0.78 | $0.92 | $0.89 | $0.76 | $0.77 | $0.70 | $0.72 | $0.68 | $0.66 | $0.65 | $0.61 |
| Weighted Average Shares Outstanding | 32.55M | 32.37M | 32.31M | 32.25M | 32.25M | 32.12M | 32.11M | 32.08M | 32.15M | 32.01M | 32.00M | 32.04M | 32.29M | 32.19M | 32.40M | 32.26M | 32.37M | 32.34M | 32.18M | 32.13M |
| Weighted Average Shares Outstanding Diluted | 32.55M | 32.78M | 32.65M | 32.63M | 32.48M | 32.48M | 32.43M | 32.41M | 32.40M | 32.37M | 32.31M | 32.48M | 32.72M | 32.64M | 32.65M | 32.66M | 32.53M | 32.52M | 32.47M | 32.52M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $49.52M | $64.45M | $66.56M | $103.24M | $84.57M |
| Short Term Investments | $- | $- | $1.41M | $- | $- |
| Cash and Short Term Investments | $49.52M | $64.45M | $66.56M | $103.24M | $84.57M |
| Net Receivables | $119.66M | $125.28M | $131.58M | $117.41M | $98.21M |
| Inventory | $130.80M | $109.52M | $119.67M | $91.06M | $70.62M |
| Other Current Assets | $13.79M | $14.99M | $18.00M | $10.53M | $13.48M |
| Total Current Assets | $313.77M | $314.24M | $335.80M | $322.23M | $266.89M |
| Property Plant Equipment Net | $299.20M | $295.90M | $290.79M | $246.81M | $236.51M |
| Goodwill | $780.03M | $778.91M | $769.51M | $523.95M | $529.46M |
| Intangible Assets | $165.05M | $191.21M | $213.29M | $94.67M | $121.66M |
| Goodwill and Intangible Assets | $945.08M | $970.12M | $982.80M | $618.61M | $651.12M |
| Long Term Investments | $- | $4.08M | $4.29M | $-46.45M | $-51.36M |
| Tax Assets | $- | $- | $62.78M | $46.45M | $51.36M |
| Other Non-Current Assets | $17.32M | $12.87M | $-51.96M | $11.67M | $11.33M |
| Total Non-Current Assets | $1.26B | $1.28B | $1.29B | $877.09M | $898.96M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $1.58B | $1.60B | $1.62B | $1.20B | $1.17B |
| Account Payables | $54.74M | $55.50M | $57.32M | $56.24M | $23.74M |
| Short Term Debt | $6.66M | $4.22M | $8.04M | $4.72M | $4.67M |
| Tax Payables | $4.47M | $4.97M | $2.28M | $1.33M | $3.45M |
| Deferred Revenue | $-3.33M | $- | $- | $- | $- |
| Other Current Liabilities | $91.82M | $83.80M | $72.40M | $81.50M | $62.56M |
| Total Current Liabilities | $157.69M | $148.49M | $140.04M | $143.80M | $94.43M |
| Long Term Debt | $34.05M | $326.11M | $456.59M | $115.68M | $169.65M |
| Deferred Revenue Non-Current | $- | $- | $- | $2.66M | $11.66M |
| Deferred Tax Liabilities Non-Current | $43.72M | $52.05M | $62.78M | $46.45M | $51.36M |
| Other Non-Current Liabilities | $190.00M | $16.58M | $89.60M | $16.37M | $22.18M |
| Total Non-Current Liabilities | $267.77M | $394.74M | $546.19M | $178.51M | $243.18M |
| Other Liabilities | $- | $1 | $- | $- | $- |
| Total Liabilities | $425.46M | $543.23M | $686.23M | $322.31M | $337.61M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $2.17M | $2.15M | $2.15M | $2.15M | $2.16M |
| Retained Earnings | $997.49M | $897.49M | $814.49M | $732.14M | $656.74M |
| Accumulated Other Comprehensive Income Loss | $-23.75M | $8.69M | $-7.15M | $-4.99M | $4.17M |
| Other Total Stockholders Equity | $174.00M | $145.65M | $128.81M | $147.72M | $165.16M |
| Total Stockholders Equity | $1.15B | $1.05B | $938.28M | $877.01M | $828.23M |
| Total Equity | $1.15B | $1.05B | $938.28M | $877.01M | $828.23M |
| Total Liabilities and Stockholders Equity | $1.58B | $1.60B | $1.62B | $1.20B | $1.17B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.58B | $1.60B | $1.62B | $1.20B | $1.17B |
| Total Investments | $- | $4.08M | $4.29M | $-46.45M | $-51.36M |
| Total Debt | $37.38M | $330.33M | $440.57M | $108.57M | $163.57M |
| Net Debt | $-12.14M | $265.89M | $374.01M | $5.33M | $79.00M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $49.52M | $73.69M | $63.74M | $60.35M | $64.45M | $76.95M | $66.86M | $60.20M | $66.56M | $56.49M | $76.18M | $64.47M | $103.24M | $90.01M | $79.90M | $88.53M | $84.57M | $78.97M | $76.41M | $73.96M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $730.00K | $1.41M | $1.61M | $1.05M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $49.52M | $73.69M | $63.74M | $60.35M | $64.45M | $76.95M | $66.86M | $60.20M | $66.56M | $56.49M | $76.18M | $64.47M | $103.24M | $90.01M | $79.90M | $88.53M | $84.57M | $78.97M | $76.41M | $73.96M |
| Net Receivables | $119.66M | $120.54M | $123.40M | $139.88M | $125.28M | $129.01M | $125.11M | $131.37M | $131.58M | $140.81M | $138.58M | $136.97M | $117.41M | $110.71M | $113.78M | $106.81M | $98.21M | $98.71M | $97.11M | $105.87M |
| Inventory | $130.80M | $118.51M | $117.10M | $110.38M | $109.52M | $116.35M | $124.95M | $124.77M | $119.67M | $139.46M | $140.84M | $108.41M | $91.06M | $81.92M | $78.33M | $77.02M | $70.62M | $77.43M | $81.55M | $83.20M |
| Other Current Assets | $13.79M | $13.25M | $15.92M | $14.25M | $14.99M | $18.91M | $19.62M | $19.27M | $18.00M | $31.35M | $21.54M | $9.95M | $10.53M | $17.63M | $15.25M | $8.84M | $13.48M | $15.02M | $8.80M | $7.66M |
| Total Current Assets | $313.77M | $325.99M | $320.16M | $324.86M | $314.24M | $341.22M | $336.53M | $335.60M | $335.80M | $368.11M | $377.14M | $319.80M | $322.23M | $300.27M | $287.26M | $281.20M | $266.89M | $270.12M | $263.86M | $270.68M |
| Property Plant Equipment Net | $299.20M | $294.76M | $290.98M | $293.04M | $295.90M | $287.06M | $289.81M | $293.62M | $290.79M | $273.83M | $265.12M | $249.63M | $246.81M | $239.08M | $237.86M | $235.22M | $236.51M | $227.74M | $223.16M | $222.19M |
| Goodwill | $780.03M | $781.11M | $770.03M | $771.54M | $778.91M | $766.54M | $773.91M | $774.36M | $769.51M | $749.03M | $731.77M | $522.59M | $523.95M | $525.42M | $527.15M | $526.25M | $529.46M | $526.26M | $522.93M | $522.78M |
| Intangible Assets | $165.05M | $177.53M | $176.10M | $182.04M | $191.21M | $192.17M | $202.98M | $209.47M | $213.29M | $227.32M | $218.80M | $88.53M | $94.67M | $101.28M | $108.25M | $113.66M | $121.66M | $126.18M | $130.87M | $136.51M |
| Goodwill and Intangible Assets | $945.08M | $958.63M | $946.13M | $953.58M | $970.12M | $958.71M | $976.90M | $983.83M | $982.80M | $976.36M | $950.57M | $611.11M | $618.61M | $626.70M | $635.40M | $639.90M | $651.12M | $652.44M | $653.79M | $659.30M |
| Long Term Investments | $- | $3.82M | $3.91M | $4.00M | $4.08M | $-59.01M | $-1.33B | $4.21M | $4.29M | $4.30M | $4.35M | $-47.03M | $-46.45M | $-51.33M | $-51.88M | $-51.87M | $-51.36M | $-57.08M | $-57.24M | $-57.09M |
| Tax Assets | $- | $- | $49.96M | $51.01M | $27.93M | $59.01M | $61.85M | $62.92M | $62.78M | $76.77M | $77.57M | $47.03M | $46.45M | $51.33M | $51.88M | $51.87M | $51.36M | $57.08M | $57.24M | $57.09M |
| Other Non-Current Assets | $17.32M | $13.74M | $-36.17M | $-37.79M | $12.87M | $16.49M | $1.28B | $-51.42M | $-51.96M | $-66.36M | $-68.08M | $14.36M | $11.67M | $13.29M | $13.08M | $12.88M | $11.33M | $11.04M | $10.44M | $9.94M |
| Total Non-Current Assets | $1.26B | $1.27B | $1.25B | $1.26B | $1.31B | $1.26B | $1.28B | $1.29B | $1.29B | $1.26B | $1.23B | $875.10M | $877.09M | $879.07M | $886.34M | $888.01M | $898.96M | $891.22M | $887.39M | $891.43M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $1.58B | $1.60B | $1.57B | $1.59B | $1.63B | $1.60B | $1.62B | $1.63B | $1.62B | $1.63B | $1.61B | $1.19B | $1.20B | $1.18B | $1.17B | $1.17B | $1.17B | $1.16B | $1.15B | $1.16B |
| Account Payables | $54.74M | $46.46M | $54.50M | $59.80M | $55.50M | $49.70M | $56.32M | $53.42M | $57.32M | $73.12M | $66.36M | $46.82M | $56.24M | $37.94M | $44.80M | $33.77M | $23.74M | $23.33M | $22.63M | $23.63M |
| Short Term Debt | $37.38M | $3.40M | $7.68M | $-7.78M | $8.44M | $7.72M | $8.18M | $3.06M | $8.04M | $7.80M | $6.34M | $4.73M | $4.72M | $4.89M | $4.58M | $4.56M | $4.67M | $3.75M | $3.99M | $4.56M |
| Tax Payables | $4.47M | $1.96M | $3.44M | $11.83M | $4.97M | $5.08M | $3.55M | $7.88M | $2.28M | $3.95M | $863.00K | $9.94M | $1.33M | $4.12M | $2.52M | $3.64M | $3.45M | $7.18M | $2.28M | $527.00K |
| Deferred Revenue | $- | $- | $3.44M | $11.83M | $30.68M | $5.08M | $3.55M | $- | $- | $76.77M | $77.57M | $- | $-58.60M | $- | $- | $3.64M | $- | $- | $2.28M | $- |
| Other Current Liabilities | $61.09M | $57.62M | $47.71M | $36.91M | $79.58M | $45.54M | $46.33M | $52.17M | $72.40M | $57.21M | $70.58M | $62.05M | $81.50M | $57.98M | $48.86M | $46.80M | $62.56M | $34.15M | $39.06M | $43.01M |
| Total Current Liabilities | $157.69M | $109.44M | $113.32M | $124.42M | $148.49M | $108.04M | $114.39M | $116.52M | $140.04M | $142.09M | $144.14M | $123.53M | $143.80M | $104.93M | $100.76M | $88.76M | $94.43M | $68.41M | $67.96M | $71.72M |
| Long Term Debt | $- | $241.89M | $282.08M | $317.44M | $326.11M | $395.81M | $420.75M | $446.82M | $456.59M | $472.81M | $443.51M | $135.56M | $115.68M | $115.56M | $130.96M | $159.99M | $169.65M | $199.59M | $222.43M | $257.90M |
| Deferred Revenue Non-Current | $- | $- | $15.51M | $15.87M | $16.54M | $- | $-482.60M | $- | $- | $- | $- | $- | $2.66M | $4.94M | $7.66M | $6.76M | $11.66M | $7.00M | $2.17M | $443.00K |
| Deferred Tax Liabilities Non-Current | $43.72M | $50.46M | $54.72M | $55.71M | $79.98M | $59.01M | $61.85M | $62.92M | $62.78M | $76.77M | $77.57M | $47.03M | $46.45M | $51.33M | $51.88M | $51.87M | $51.36M | $57.08M | $57.24M | $57.09M |
| Other Non-Current Liabilities | $224.05M | $17.93M | $67.20M | $68.05M | $44.51M | $15.36M | $15.34M | $29.09M | $89.60M | $45.42M | $117.65M | $7.08M | $16.37M | $69.79M | $20.36M | $70.97M | $22.18M | $9.83M | $68.34M | $66.22M |
| Total Non-Current Liabilities | $267.77M | $310.28M | $349.28M | $385.48M | $422.67M | $470.18M | $497.94M | $538.83M | $546.19M | $595.00M | $561.16M | $197.70M | $178.51M | $185.34M | $203.21M | $230.96M | $243.18M | $273.49M | $290.77M | $324.12M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $425.46M | $419.72M | $462.60M | $509.91M | $571.16M | $578.22M | $612.33M | $655.35M | $686.23M | $737.09M | $705.30M | $321.23M | $322.31M | $290.27M | $303.96M | $319.72M | $337.61M | $341.90M | $358.73M | $395.84M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $2.17M | $2.16M | $2.16M | $2.15M | $2.15M | $2.15M | $2.15M | $2.15M | $2.14M | $2.14M | $2.14M | $2.15M | $2.17M | $2.17M | $2.17M | $2.16M | $2.16M | $2.16M | $2.16M |
| Retained Earnings | $- | $992.38M | $958.54M | $926.47M | $897.49M | $896.38M | $867.31M | $837.20M | $814.49M | $816.09M | $790.84M | $761.06M | $732.14M | $727.89M | $702.88M | $680.15M | $656.74M | $653.38M | $631.81M | $610.69M |
| Accumulated Other Comprehensive Income Loss | $-23.75M | $14.50M | $-7.13M | $-3.87M | $8.69M | $-14.23M | $191.00K | $1.86M | $-7.15M | $-46.87M | $-12.42M | $-6.29M | $-4.99M | $-2.58M | $432.00K | $-1.45M | $4.17M | $-1.22M | $-5.89M | $-8.47M |
| Other Total Stockholders Equity | $1.17B | $168.17M | $158.79M | $154.03M | $145.65M | $140.97M | $137.25M | $132.21M | $128.81M | $124.56M | $120.81M | $116.77M | $147.72M | $161.60M | $164.16M | $168.63M | $165.16M | $165.11M | $164.44M | $161.89M |
| Total Stockholders Equity | $1.15B | $1.18B | $1.11B | $1.08B | $1.05B | $1.03B | $1.01B | $973.42M | $938.28M | $895.92M | $901.37M | $873.68M | $877.01M | $889.08M | $869.64M | $849.49M | $828.23M | $819.44M | $792.52M | $766.27M |
| Total Equity | $1.15B | $1.18B | $1.11B | $1.08B | $1.05B | $1.03B | $1.01B | $973.42M | $938.28M | $895.92M | $901.37M | $873.68M | $877.01M | $889.08M | $869.64M | $849.49M | $828.23M | $819.44M | $792.52M | $766.27M |
| Total Liabilities and Stockholders Equity | $1.58B | $1.60B | $1.57B | $1.59B | $1.63B | $1.60B | $1.62B | $1.63B | $1.62B | $1.63B | $1.61B | $1.19B | $1.20B | $1.18B | $1.17B | $1.17B | $1.17B | $1.16B | $1.15B | $1.16B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.58B | $1.60B | $1.57B | $1.59B | $1.63B | $1.60B | $1.62B | $1.63B | $1.62B | $1.63B | $1.61B | $1.19B | $1.20B | $1.18B | $1.17B | $1.17B | $1.17B | $1.16B | $1.15B | $1.16B |
| Total Investments | $- | $3.82M | $3.91M | $4.00M | $4.08M | $-59.01M | $-1.33B | $4.21M | $4.29M | $4.30M | $4.35M | $-47.03M | $-46.45M | $-51.33M | $-51.88M | $-51.87M | $-51.36M | $-57.08M | $-57.24M | $-57.09M |
| Total Debt | $34.05M | $245.29M | $285.92M | $321.49M | $330.33M | $380.57M | $424.85M | $431.57M | $440.57M | $476.71M | $446.68M | $137.92M | $108.57M | $118.00M | $123.57M | $162.27M | $163.57M | $193.57M | $224.42M | $260.18M |
| Net Debt | $-15.46M | $171.60M | $222.18M | $261.14M | $265.89M | $303.62M | $357.99M | $371.37M | $374.01M | $420.22M | $370.50M | $73.46M | $5.33M | $27.99M | $43.67M | $73.74M | $79.00M | $114.60M | $148.02M | $186.22M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $128.47M | $108.54M | $105.37M | $96.10M | $84.62M |
| Depreciation and Amortization | $47.97M | $54.94M | $51.85M | $48.88M | $51.28M |
| Deferred Income Tax | $-6.78M | $-10.81M | $-8.36M | $-5.94M | $-4.63M |
| Stock Based Compensation | $16.68M | $16.05M | $13.22M | $10.80M | $8.30M |
| Change in Working Capital | $-6.12M | $20.01M | $-25.22M | $10.93M | $8.53M |
| Accounts Receivables | $- | $6.97M | $-3.62M | $-20.70M | $-3.60M |
| Inventory | $- | $10.53M | $-7.80M | $-21.02M | $13.92M |
| Accounts Payables | $- | $- | $-15.54M | $46.19M | $-3.85M |
| Other Working Capital | $-6.12M | $2.51M | $1.74M | $6.47M | $2.06M |
| Other Non Cash Items | $1.77M | $-4.96M | $1.68M | $-257.00K | $2.38M |
| Net Cash Provided by Operating Activities | $182.00M | $183.76M | $138.54M | $160.51M | $150.49M |
| Investments in Property Plant and Equipment | $- | $-37.89M | $-50.29M | $-37.45M | $-33.83M |
| Acquisitions Net | $-24.43M | $-1.54M | $-365.78M | $318.00K | $87.00K |
| Purchases of Investments | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $2.74M | $- | $- | $- |
| Other Investing Activities | $-35.30M | $1.88M | $56.00K | $1.83M | $-850.00K |
| Net Cash Used for Investing Activities | $-59.74M | $-34.81M | $-416.01M | $-35.30M | $-34.59M |
| Debt Repayment | $-119.78M | $-131.22M | $300.83M | $-55.16M | $-85.15M |
| Common Stock Issued | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-5.68M | $-4.47M | $-35.42M | $-35.24M | $-13.46M |
| Dividends Paid | $-25.58M | $-22.87M | $-20.71M | $-18.72M | $-16.70M |
| Other Financing Activities | $17.23M | $5.24M | $1.98M | $6.94M | $14.15M |
| Net Cash Used Provided by Financing Activities | $-133.81M | $-153.32M | $246.68M | $-102.18M | $-101.16M |
| Effect of Forex Changes on Cash | $-3.38M | $2.26M | $-5.88M | $-4.37M | $4.16M |
| Net Change in Cash | $-14.93M | $-2.11M | $-36.68M | $18.67M | $18.90M |
| Cash at End of Period | $49.52M | $64.45M | $66.56M | $103.24M | $84.57M |
| Cash at Beginning of Period | $64.45M | $66.56M | $103.24M | $84.57M | $65.67M |
| Operating Cash Flow | $182.00M | $183.76M | $138.54M | $160.51M | $150.49M |
| Capital Expenditure | $- | $-37.89M | $-50.29M | $-37.45M | $-33.83M |
| Free Cash Flow | $182.00M | $145.87M | $88.25M | $123.06M | $116.67M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $33.58M | $33.84M | $32.07M | $28.99M | $26.65M | $29.07M | $30.11M | $22.71M | $21.41M | $25.25M | $29.78M | $28.93M | $24.95M | $25.01M | $22.73M | $23.41M | $22.16M | $21.57M | $21.12M | $19.77M |
| Depreciation and Amortization | $10.90M | $10.90M | $12.51M | $13.67M | $13.53M | $13.80M | $13.43M | $13.65M | $13.89M | $14.10M | $11.93M | $11.93M | $12.26M | $12.16M | $12.10M | $12.36M | $12.93M | $13.05M | $12.74M | $12.55M |
| Deferred Income Tax | $-4.86M | $-802.00K | $-814.00K | $-302.00K | $-8.39M | $-1.85M | $-370.00K | $-203.00K | $-9.88M | $-265.00K | $1.78M | $37.00K | $-5.14M | $-860.00K | $54.00K | $- | $-5.16M | $146.00K | $251.00K | $135.00K |
| Stock Based Compensation | $3.89M | $4.15M | $3.89M | $4.75M | $3.79M | $3.75M | $3.75M | $4.77M | $3.39M | $2.95M | $3.81M | $3.08M | $1.99M | $2.90M | $3.29M | $2.62M | $1.55M | $2.25M | $2.32M | $2.18M |
| Change in Working Capital | $7.93M | $2.33M | $-3.31M | $-13.07M | $32.45M | $3.49M | $-9.54M | $-6.40M | $10.57M | $985.00K | $477.00K | $-37.25M | $9.26M | $1.41M | $-2.11M | $2.37M | $16.46M | $-1.73M | $6.36M | $-12.57M |
| Accounts Receivables | $362.00K | $4.01M | $16.22M | $-15.01M | $4.36M | $-4.01M | $6.22M | $403.00K | $11.06M | $828.00K | $4.90M | $-20.41M | $-6.61M | $2.27M | $-6.75M | $-9.61M | $1.38M | $-815.00K | $9.35M | $-13.52M |
| Inventory | $-14.05M | $-393.00K | $-6.89M | $-1.46M | $7.99M | $7.88M | $-187.00K | $-5.14M | $22.57M | $2.77M | $-15.54M | $-17.60M | $-9.29M | $-3.79M | $-1.25M | $-6.70M | $7.12M | $4.46M | $1.81M | $528.00K |
| Accounts Payables | $- | $6.88M | $-2.29M | $-4.58M | $9.98M | $1.71M | $-2.98M | $-5.11M | $-15.07M | $-717.00K | $15.07M | $-7.71M | $19.51M | $3.66M | $11.67M | $10.34M | $3.97M | $3.34M | $-7.71M | $-3.10M |
| Other Working Capital | $21.63M | $-8.17M | $-10.35M | $7.99M | $10.12M | $-2.08M | $-12.59M | $3.46M | $-7.99M | $-1.90M | $-3.95M | $8.46M | $5.65M | $-739.00K | $-5.78M | $8.34M | $3.99M | $-8.71M | $2.91M | $3.52M |
| Other Non Cash Items | $876.00K | $886.00K | $22.51M | $52.49M | $-619.00K | $-1.75M | $-2.39M | $314.00K | $2.28M | $-1.40M | $458.00K | $336.00K | $1.17M | $-980.00K | $-284.00K | $-161.00K | $6.00K | $64.00K | $1.81M | $499.00K |
| Net Cash Provided by Operating Activities | $52.32M | $51.30M | $44.99M | $33.39M | $67.41M | $46.53M | $34.99M | $34.84M | $41.66M | $41.62M | $48.24M | $7.02M | $44.49M | $39.63M | $35.78M | $40.61M | $47.95M | $35.36M | $44.62M | $22.57M |
| Investments in Property Plant and Equipment | $-12.72M | $-9.15M | $-6.88M | $-6.91M | $-11.57M | $-8.37M | $-8.23M | $-9.72M | $-14.50M | $-14.99M | $-10.54M | $-10.26M | $-15.06M | $-8.63M | $-7.45M | $-6.31M | $-13.28M | $-7.29M | $-7.87M | $-5.39M |
| Acquisitions Net | $-24.32M | $-33.00K | $59.00K | $213.00K | $-290.00K | $-911.00K | $1.88M | $-341.00K | $150.00K | $-70.12M | $-295.66M | $184.00K | $-954.00K | $1.03M | $154.00K | $86.00K | $87.00K | $- | $- | $- |
| Purchases of Investments | $- | $80.00K | $-38.00K | $-42.00K | $-290.00K | $- | $-4.62M | $- | $150.00K | $- | $-150.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $2.74M | $- | $-150.00K | $- | $150.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $87.00K | $-80.00K | $59.00K | $213.00K | $290.00K | $- | $4.62M | $-56.00K | $-142.00K | $1.00K | $-137.00K | $184.00K | $877.00K | $1.03M | $154.00K | $86.00K | $-22.00K | $-500.00K | $-328.00K | $-5.39M |
| Net Cash Used for Investing Activities | $-36.96M | $-9.18M | $-6.86M | $-6.74M | $-11.87M | $-9.28M | $-3.61M | $-10.06M | $-14.49M | $-85.11M | $-306.34M | $-10.07M | $-14.18M | $-7.60M | $-7.29M | $-6.23M | $-13.21M | $-7.79M | $-8.20M | $-5.39M |
| Debt Repayment | $-37.05M | $-39.63M | $-35.05M | $-8.06M | $-71.06M | $-25.06M | $-26.05M | $-9.05M | $-22.26M | $28.82M | $274.31M | $19.96M | $-41.00K | $-15.04M | $-30.04M | $-10.04M | $-30.04M | $-25.11M | $-35.00M | $5.00M |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-306.00K | $-163.00K | $-11.00K | $-5.20M | $-444.00K | $-101.00K | $-75.00K | $-3.85M | $-178.00K | $-46.00K | $-600.00K | $-34.60M | $-16.48M | $-7.93M | $-9.24M | $-1.60M | $-7.48M | $-2.96M | $-2.13M | $-891.00K |
| Dividends Paid | $-4.00K | $-4.00K | $-13.00K | $-25.55M | $- | $-3.00K | $-2.00K | $-22.87M | $-5.00K | $-4.00K | $-1.00K | $-20.70M | $-19.00K | $-4.00K | $- | $-18.70M | $-1.00K | $- | $- | $-16.70M |
| Other Financing Activities | $2.14M | $5.40M | $891.00K | $8.79M | $1.35M | $62.00K | $1.37M | $2.45M | $1.04M | $-388.00K | $830.00K | $498.00K | $592.00K | $2.46M | $1.48M | $2.40M | $5.98M | $1.38M | $2.37M | $4.43M |
| Net Cash Used Provided by Financing Activities | $-35.21M | $-34.39M | $-34.19M | $-30.02M | $-70.15M | $-25.10M | $-24.76M | $-33.32M | $-21.40M | $28.39M | $274.54M | $-34.84M | $-15.95M | $-20.51M | $-37.79M | $-27.93M | $-31.55M | $-26.69M | $-34.77M | $-8.16M |
| Effect of Forex Changes on Cash | $-4.32M | $2.23M | $-559.00K | $-724.00K | $2.10M | $-2.06M | $36.00K | $2.18M | $4.31M | $-4.59M | $-4.72M | $-877.00K | $-1.14M | $-1.42M | $673.00K | $-2.48M | $2.41M | $1.68M | $799.00K | $-724.00K |
| Net Change in Cash | $-24.18M | $9.96M | $3.39M | $-4.10M | $-12.51M | $10.10M | $6.66M | $-6.36M | $10.07M | $-19.69M | $11.72M | $-38.77M | $13.23M | $10.11M | $-8.63M | $3.96M | $5.60M | $2.56M | $2.45M | $8.29M |
| Cash at End of Period | $49.52M | $73.69M | $63.74M | $60.35M | $64.45M | $76.95M | $66.86M | $60.20M | $66.56M | $56.49M | $76.18M | $64.47M | $103.24M | $90.01M | $79.90M | $88.53M | $84.57M | $78.97M | $76.41M | $73.96M |
| Cash at Beginning of Period | $73.69M | $63.74M | $60.35M | $64.45M | $76.95M | $66.86M | $60.20M | $66.56M | $56.49M | $76.18M | $64.47M | $103.24M | $90.01M | $79.90M | $88.53M | $84.57M | $78.97M | $76.41M | $73.96M | $65.67M |
| Operating Cash Flow | $52.32M | $51.30M | $44.99M | $33.39M | $67.41M | $46.53M | $34.99M | $34.84M | $41.66M | $41.62M | $48.24M | $7.02M | $44.49M | $39.63M | $35.78M | $40.61M | $47.95M | $35.36M | $44.62M | $22.57M |
| Capital Expenditure | $-12.72M | $-9.15M | $-6.88M | $-6.91M | $-11.57M | $-8.37M | $-8.23M | $-9.72M | $-14.50M | $-14.99M | $-10.54M | $-10.26M | $-15.06M | $-8.63M | $-7.45M | $-6.31M | $-13.28M | $-7.29M | $-7.87M | $-5.39M |
| Free Cash Flow | $39.59M | $42.15M | $38.11M | $26.48M | $55.83M | $38.16M | $26.76M | $25.12M | $27.16M | $26.63M | $37.70M | $-3.23M | $29.43M | $31.00M | $28.33M | $34.30M | $34.68M | $28.07M | $36.74M | $17.17M |
Balchem Dividends
Explore Balchem's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
0.49%
Dividend Payout Ratio
19.91%
Dividend Paid & Capex Coverage Ratio
7.12x
Balchem Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.87 | $0.87 | December 26, 2024 | December 26, 2024 | January 17, 2025 | December 10, 2024 |
| $0.79 | $0.79 | December 26, 2023 | December 27, 2023 | January 19, 2024 | December 04, 2023 |
| $0.71 | $0.71 | December 23, 2022 | December 27, 2022 | January 20, 2023 | December 06, 2022 |
| $0.64 | $0.64 | December 27, 2021 | December 28, 2021 | January 21, 2022 | December 16, 2021 |
| $0.58 | $0.58 | December 24, 2020 | December 28, 2020 | January 22, 2021 | December 17, 2020 |
| $0.52 | $0.52 | December 27, 2019 | December 30, 2019 | January 17, 2020 | December 18, 2019 |
| $0.47 | $0.47 | December 24, 2018 | December 26, 2018 | January 18, 2019 | December 12, 2018 |
| $0.42 | $0.42 | December 26, 2017 | December 27, 2017 | January 19, 2018 | December 13, 2017 |
| $0.38 | $0.38 | December 22, 2016 | December 27, 2016 | January 20, 2017 | December 15, 2016 |
| $0.34 | $0.34 | December 23, 2015 | December 28, 2015 | January 21, 2016 | December 18, 2015 |
| $0.3 | $0.3 | December 24, 2014 | December 29, 2014 | January 27, 2015 | December 22, 2014 |
| $0.26 | $0.26 | December 19, 2013 | December 23, 2013 | January 21, 2014 | December 13, 2013 |
| $0.22 | $0.22 | December 12, 2012 | December 14, 2012 | December 21, 2012 | December 04, 2012 |
| $0.18 | $0.18 | December 12, 2011 | December 14, 2011 | January 16, 2012 | December 09, 2011 |
| $0.15 | $0.15 | December 17, 2010 | December 21, 2010 | January 20, 2011 | December 14, 2010 |
| $0.11 | $0.07333337 | December 28, 2009 | December 30, 2009 | January 20, 2010 | December 14, 2009 |
| $0.11 | $0.07333337 | December 18, 2008 | December 22, 2008 | January 20, 2009 | December 12, 2008 |
| $0.11 | $0.07333337 | December 18, 2007 | December 20, 2007 | January 18, 2008 | December 07, 2007 |
| $0.09 | $0.04 | December 27, 2006 | December 29, 2006 | January 19, 2007 | December 12, 2006 |
| $0.09 | $0.02666671 | December 28, 2005 | December 30, 2005 | January 20, 2006 | December 15, 2005 |
Balchem News
Read the latest news about Balchem, including recent articles, headlines, and updates.
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025.
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry
Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call.
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025
MONTVALE, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 21, 2025, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2024 results.
Balchem Corporation to Present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025
MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025.
Industrial Chemicals: 3 Stocks Poised for Growth in the New Year
The chemicals industry—companies creating chemicals used in industrial, commercial, and a variety of other applications—thrived for many years leading up to and including the COVID-19 pandemic. However, a recent report by McKinsey & Co. shows that the period since the end of the pandemic has brought a sharp reversal of this trend, with chemicals companies as a group achieving growth of under 2% per year since late 2022 while global indexes have increased 24% per year over the same period.
Recent Price Trend in Blachem (BCPC) is Your Friend, Here's Why
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Balchem Corporation Announces Dividend
MONTVALE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2024, its Board of Directors declared a dividend on its shares of common stock equal to $0.87 per share on the Company's issued and outstanding Common Stock, to be payable on January 17, 2025 to stockholders of record at the close of business on December 26, 2024.
Blachem (BCPC) Is a Great Choice for 'Trend' Investors, Here's Why
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Balchem Corporation to Present at Baird's 54th Annual Global Industrial Conference on November 13, 2024
MONTVALE, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 54th Annual Global Industrial Conference on November 13, 2024.
Balchem's Q3 Shows Record Earnings And Valuation Pressure
Balchem Corporation shows strong long-term growth potential in high-margin segments and product innovation, but faces challenges in Animal Nutrition & Health and rising costs. Balchem's financial momentum in Q3 2024 includes record earnings, improved margins, and significant debt reduction, despite missing revenue estimates. BCPC stock's high P/E ratio of 39.82x suggests big market expectations, but the current valuation may be too high given existing challenges.
Balchem Corporation (BCPC) Q3 2024 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q3 2024 Earnings Conference Call October 25, 2024 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, President and Chief Executive Officer Conference Call Participants Robert Labick - CJS Securities Raghuram Selvaraju - H.C. Wainwright & Co Kyle May - Sidoti and Company Operator Greetings, and welcome to the Balchem's Third Quarter 2024 Earnings Call.
Balchem Corporation Reports Third Quarter 2024 Financial Results
MONTVALE, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal third quarter ended September 30, 2024. For the quarter, the Company reported net sales of $239.9 million, net earnings of $33.8 million, adjusted EBITDA(a) of $64.4 million, and free cash flow(a) of $42.2 million.
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024
MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review third quarter results.
Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024
MONTVALE, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for BCPC.